Patents Examined by Charles F. Warren
  • Patent number: 4940840
    Abstract: Novel bacteria strains are decribed which are created by the introduction of DNA encoding for the production of chitinase, an enzyme capable of degrading chitin present in fungi and nematodes. The strains have utility in producing chitinase for the purpose of inhibiting plant pathogens. Novel pathogen-resistant plants are also described which are created by introduction of DNA encoding for the production of chitinase.
    Type: Grant
    Filed: July 18, 1986
    Date of Patent: July 10, 1990
    Assignee: DNA Plant Technology Corporation
    Inventors: Trevor V. Suslow, Jonathan D. G. Jones
  • Patent number: 4940835
    Abstract: This invention involves a cloning or expression vector comprising a gene which encodes 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) polypeptide which, when expressed in a plant cell contains a chloroplast transit peptide which allows the polypeptide, or an enzymatically active portion thereof, to be transported from the cytoplasm of the plant cell into a chloroplast in the plant cell, and confers a substantial degree of glyphosate resistance upon the plant cell and plants regenerated therefrom.The EPSPS coding sequence may be ligated to a strong promoter, such as the 35S promoter from cauliflower mosaic virus, to create a chimeric gene. Such genes can be inserted into plant transformation vectors, and subsequently introduced into plant cells. Plant cells transformed using such genes and plants regenerated therefrom have been shown to exhibit a substantial degree of glyphosate resistance.
    Type: Grant
    Filed: July 7, 1986
    Date of Patent: July 10, 1990
    Assignee: Monsanto Company
    Inventors: Dilip M. Shah, Stephen G. Rogers, Robert B. Horsch, Robert T. Fraley
  • Patent number: 4940839
    Abstract: The present invention relates to a method of producing a hybrid plant of a wild species and a cultivated species of Lycopersicon which comprises fusing protoplasts of the wild and cultivated species and recovering a hybrid plant from fused protoplasts under selective regeneration conditions wherein the wild species is incapable of regeneration under said conditions.
    Type: Grant
    Filed: October 1, 1986
    Date of Patent: July 10, 1990
    Assignee: DNA Plant Technology Corporation
    Inventors: Janis E. Bravo, David A. Evans
  • Patent number: 4940836
    Abstract: Somatic hybrids of Rutaceae plants were obtained by allowing the protoplasts from embryogenic cells of a Rutaceae plant, which are of the nucellar origin, resistant to fusion treatment, and have a high proliferation activity, to fuse with the protoplasts of another Rutaceae plant having no proliferation activity, and then cultivating the fused protoplasts in a medium not containing a phytohormone but containing a saccharide in a concentration suitable for the selective embryogenesis of the hybrid cells.
    Type: Grant
    Filed: October 1, 1985
    Date of Patent: July 10, 1990
    Assignees: Director General of Fruit Tree Research Station Ministry of Agriculture, Forestry and Fisheries, Kikkoman Corporation
    Inventors: Shigetaka Ishii, Toshifumi Ohgawara, Shozo Kobayashi, Iwao Oiyama, Katsuichi Yoshinaga
  • Patent number: 4938898
    Abstract: The present invention relates to improved processes for selectively chlorinating acyl compounds at the alpha or 2-position. The process of the present invention comprises a method of producing alpha-chloro acyl chlorides comprising contacting an acyl chloride with a chlorine source at a temperature of about 75.degree. C. to about 125.degree. C. in the presence of (i) an effective amount of an auxiliary acidic agent and (ii) an effective amount of a food grade antioxidant and optionally (iii) an effective amount of oxygen or air.
    Type: Grant
    Filed: June 29, 1984
    Date of Patent: July 3, 1990
    Assignee: The Procter & Gamble Company
    Inventor: James E. Thompson
  • Patent number: 4935355
    Abstract: A process for forming a dipeptide which is substantially free of solid dipeptide-amino acid adduct by reacting the amino acid reactants in the presence of a polyol.
    Type: Grant
    Filed: April 15, 1986
    Date of Patent: June 19, 1990
    Assignee: Synthetech, Inc.
    Inventors: Duane C. Ulmer, Mary S. Rosendahl
  • Patent number: 4935372
    Abstract: A gene and gene product that regulates the expression of the capsidal envelope genes of HTLV-III/LAV and that can be used to regulate the expression of heterologous (non-viral) genes as well is disclosed. This art gene consists of two exons and can be used in creating nucleotide segments, vectors and cell lines. A new method for screening for compounds that inhibit the replication of HTLV-III is also described and comprises:(1) transfecting a T-cell line with the HTLV-III art and env genes;(2) thereafter, adding a preselected compound to the transformed cell line in increasing concentrations; and(3) determining whether the compound effects the art function without being toxic to the cell.An additional parameter to use in diagnosis of AIDS disease is also described. The use of the art gene and gene product in AIDS therapy is also disclosed.
    Type: Grant
    Filed: May 20, 1986
    Date of Patent: June 19, 1990
    Assignee: Dana Farber Cancer Institute
    Inventor: Wei C. Goh
  • Patent number: 4935362
    Abstract: A new antitumor antibiotic designated herein as BMY-28121 is produced by fermentation of Streptomyces albus strain K7331-113 (ATCC 39897). BMY-28121, which may be recovered from the fermentation broth in either its natural free hydroxy form (BMY-28121A) or methyl ether form (BMY-28121B), inhibits gram-positive bacteria and anaerobes and inhibits the growth of mammalian tumors such as P-388 leukemia, L-1210 leukemia and B16 melanoma.
    Type: Grant
    Filed: March 30, 1987
    Date of Patent: June 19, 1990
    Assignee: Bristol-Myers Company
    Inventors: Mitsuaki Tsunakawa, Masataka Konishi, Takeo Miyaki
  • Patent number: 4933114
    Abstract: A photopolymerizable monomer comprising a lipid having at least one hydrophobic acyl chain containing at least two conjugated acetylenic linkages is useful in preparing radiation-sensitive compositions and photographic elements comprising a plurality of liposomes. Further, processes for photopolymerizing the radiation-sensitive compositions and for forming an image in the photographic elements comprise exposing the lipid to radiation, heating the lipid to a temperature equal to or above a first transition temperature of the lipid to render it insensitive to further exposure, and optionally cooling the lipid to a temperature equal to or below a seocnd phase transition temperature of the lipid to render it again sensitive to further exposure. The monomeric lipids, when photopolymerized, form polymeric lipids exhibiting decreased solubility and liposome wall permeability as compared to the unpolymerized monomeric lipids.
    Type: Grant
    Filed: October 21, 1981
    Date of Patent: June 12, 1990
    Assignee: Eastman Kodak Company
    Inventors: David F. O'Brien, Thomas H. Whitesides, Richard T. Klingbiel
  • Patent number: 4933282
    Abstract: A process for preparing an optically active .gamma.-halo-.beta.-hydroxybutyric acid ester in high yields which comprises subjecting a .gamma.-haloacetoacetic acid ester to the action of a microorganism selected from genus Saccharomyces under an anaerobic condition. When the .gamma.-haloacetoacetic acid ester is subjected to the action of the microorganism in the presence of a ketal, the yield and optical purity can be further increased.
    Type: Grant
    Filed: November 26, 1986
    Date of Patent: June 12, 1990
    Assignee: Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha
    Inventors: Masayasu Hasegawa, Shigetaka Okada, Nobutake Hamada, Kiyofumi Sakai, You Honda
  • Patent number: 4931399
    Abstract: The invention relates to a method for microbiologically resolving racemic 2,3-o-substituted glycerol esters to obtain optically activated 2,3-o-substituted glycerol with remaining esters also being optically active.
    Type: Grant
    Filed: September 9, 1985
    Date of Patent: June 5, 1990
    Assignee: The Wisconsin Alumni Research Foundation
    Inventor: Charles J. Sih
  • Patent number: 4931394
    Abstract: Angiosperm nodes are cultured to develop plantlets. The plantlets are exposed to photoperiods of light and dark. Leaf tissue removed from the plantlets when cultured produces at least 20% embryos.
    Type: Grant
    Filed: October 31, 1988
    Date of Patent: June 5, 1990
    Assignee: The Board of Governors for Higher Education, State of Rhode Island and Providence Plantations
    Inventor: William R. Krul
  • Patent number: 4929764
    Abstract: By reacting a primary aromatic amine with a dialkyl ether in the presence of a titanium dioxide alkylation catalyst having a surface area below about 130 square meters per gram, preferably in the anatase crystallographic form, at a suitably elevated temperature above about 300.degree. C., the amount of exclusively ring-alkylated product formed exceeds the amount of exclusively N-alkylated product formed.
    Type: Grant
    Filed: September 16, 1985
    Date of Patent: May 29, 1990
    Assignee: Ethyl Corporation
    Inventor: Duane C. Hargis
  • Patent number: 4927762
    Abstract: Cells grown in chemically defined (serum free) media are protected against endogenous oxidizing agents by a nontoxic antioxidant with free thiol groups, at cell densities less than about 10.sup.5 cells/ml, especially DL-penicillamine, N-acetylcysteine, mercaptoproprionic acid, 2-mercaptoethanesulfonic acid, and thiolactate. These agensts are useful in the maintenance and growth of hybridomas in such media.
    Type: Grant
    Filed: November 30, 1988
    Date of Patent: May 22, 1990
    Assignee: Cell Enterprises, Inc.
    Inventor: Frederick J. Darfler
  • Patent number: 4927754
    Abstract: The object of this invention is to provide a method for selectively increasing the ratio of the single T-A2 major components in the T-A2 complex. More particularly, the object of this invention is a process for obtaining teicoplanin A.sub.2 selectively enriched in any of its major components, T-A2-1, T-A2-2, T-A2-3, T-A2-4 and T-A2-5 which consists in adding to the culture medium of Actinoplanes teichomyceticus nov. sp. ATCC 31121 or a mutant thereof which produces T-A2 complex through the same metabolic pathway, a selectively effective amount of an appropriate precursor.
    Type: Grant
    Filed: May 19, 1986
    Date of Patent: May 22, 1990
    Assignee: Gruppo Lepetit S.p.A.
    Inventors: Francesco Assi, Giancarlo Lancini, Anacleto Gianantonio
  • Patent number: 4925790
    Abstract: A method is provided for producing a product by enzyme-catalyzed reaction using supercritical fluid as a solvent. Improved reaction times, conversion efficiencies and/or other efficiencies (such as improved ease of product recovery) are obtained.
    Type: Grant
    Filed: August 30, 1985
    Date of Patent: May 15, 1990
    Assignee: The Regents of the University of California
    Inventors: Harvey W. Blanch, Theodore Randolph, Charles R. Wilke
  • Patent number: 4923403
    Abstract: A process for preparing 3a.alpha.-H-4.alpha.-[3'-propionic acid]-5.alpha.-hydroxy-7a.beta.-methyl-hexahydro-1-indanone-.delta.-lacton e, having the formula ##STR1## for the chemical synthesis of a pharmaceutical steroid, which includes cultivating, in the presence of cholesterol, sitosterol, stigmasterol, or a mixture of sitosterol and sitostanol, a mutant of the parent species R. australis of the genus Rhodococcus.
    Type: Grant
    Filed: August 15, 1985
    Date of Patent: May 8, 1990
    Assignee: South African Inventions Development Corp.
    Inventor: Nicolaas P. Ferreira
  • Patent number: 4921802
    Abstract: A method is disclosed for detecting RNA viral infections in plants comprising the isolation of an RNA molecule, e.g., from alfalfa mosaic virus (AMV), production of full-length cDNA transcripts, cloning into plasmids and propgation of the recombinant plasmid. This recombinant DNA plasmid is utilized diagostically to test a plant for infection by a virus, e.g., AMV.
    Type: Grant
    Filed: January 13, 1988
    Date of Patent: May 1, 1990
    Assignee: Pioneer Hi-Bred International, Inc.
    Inventors: Timothy C. Hall, L. Sue Loesch-Fries, Nancy P. Jarvis, Richard F. Barker
  • Patent number: 4921504
    Abstract: The compound 4-(N-ethyl-N-2'-hydroxyethyl)-amino-1-(2"-hydroxyethyl)-amino-2-nitrobenze ne, having the formula: ##STR1## is provided for use as a blue coloring nitro dye in a hair dyeing composition that may be directly applied to hair without the use of oxidation agents.
    Type: Grant
    Filed: September 12, 1988
    Date of Patent: May 1, 1990
    Assignee: Wella Aktiengesellschaft
    Inventors: Thomas Clausen, Eugen Konrad
  • Patent number: 4918011
    Abstract: 3',4'-anhydrovinblastine, a precursor of the anti-tumor alkaloids vincristine and vinblastine, is prepared by the enzymatic coupling of catharanthine and vindoline using an iron-containing compound such as peroxidase optionally in the presence of a peroxide. Substantially enhanced yields are obtained.
    Type: Grant
    Filed: August 4, 1986
    Date of Patent: April 17, 1990
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Anne E. Goodbody, Endo Tsuyoshi, John Vukovic, Masanaru Misawa